Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transthyretin Cardiac Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02792790
What this trial is testing

Carpal Tunnel Syndrome and Amyloid Cardiomyopathy

Who this might be right for
AmyloidosisCardiomyopathyTransthyretin Amyloidosis+2 more
The Cleveland Clinic 96
Not applicableNot Yet RecruitingNCT07343999
What this trial is testing

EFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac Amyloidosis

Who this might be right for
Transthyretin Cardiac Amyloidosis
Universidad de Burgos 102
Not applicableStudy completedNCT03886155
What this trial is testing

Cardiac Amyloidosis Screening at Trigger Finger Release

Who this might be right for
AmyloidosisTrigger FingerTransthyretin Amyloidosis+1 more
The Cleveland Clinic 107
Not applicableStudy completedNCT04828928
What this trial is testing

Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)

Who this might be right for
Wild-type Amyloid Cardiopathy
University Hospital, Bordeaux 65
Not applicableStudy completedNCT04801329
What this trial is testing

Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy

Who this might be right for
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Pfizer 110
Not applicableActive Not RecruitingNCT07494656
What this trial is testing

A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

Who this might be right for
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Pfizer 1
Not applicableLooking for participantsNCT05444920
What this trial is testing

The Italian Transthyretin Amyloidosis Web-Network

Who this might be right for
ATTR Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 1,000
Not applicableActive Not RecruitingNCT06651073
What this trial is testing

ATTR-CM: A Multi-country, Non-interventional Disease Registry

Who this might be right for
Transthyretin Amyloid Cardiopathy
Pfizer 350
Testing effectiveness (Phase 2)Study completedNCT01981837
What this trial is testing

Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

Who this might be right for
TTR-mediated Amyloidosis
Alnylam Pharmaceuticals 26
Not applicableUnknownNCT04956965
What this trial is testing

High Resolution Three-dimensional Maps of the Right Chambers in Patient Diagnosed With Cardiac Amyloidosis

Who this might be right for
Cardiac AmyloidosisCardiac Disease
University Hospital Center of Martinique 24
Not applicableLooking for participantsNCT07213297
What this trial is testing

Comprehensive Program for Hereditary Transthyretin Amyloidosis

Who this might be right for
Amyloidosis in Transthyretin (TTR)Amyloidosis, Familial
Hospital de Alta Complejidad en Red 20
Not applicableWithdrawnNCT07080268
What this trial is testing

Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.

Who this might be right for
Amyloidosis in Transthyretin (TTR)Hereditary Amyloidosis, Transthyretin-Related
Hospital General de Niños Pedro de Elizalde
Not applicableStudy completedNCT03923920
What this trial is testing

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Who this might be right for
AmyloidAmyloidosisSpinal Stenosis+2 more
The Cleveland Clinic 200
Not applicableActive Not RecruitingNCT07062848
What this trial is testing

An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Yale University 1,500,000
Not applicableNot Yet RecruitingNCT07538518
What this trial is testing

PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

Who this might be right for
Amyloidogenic Transthyretin (ATTR) AmyloidosisCardiac Amyloidosis
Lorena Saelices 25
Not applicableLooking for participantsNCT05489549
What this trial is testing

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Who this might be right for
Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, Familial+2 more
University of Texas Southwestern Medical Center 500
Not applicableLooking for participantsNCT06907836
What this trial is testing

Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine

Who this might be right for
Cardiac Amyloidosis
University Hospital, Strasbourg, France 30
Not applicableLooking for participantsNCT06907186
What this trial is testing

An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Hereditary Transthyretin Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07116473
What this trial is testing

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

Who this might be right for
Amyloidosis in Transthyretin (TTR)Amyloidosis, FamilialAmyloid Cardiomyopathy+7 more
Eidos Therapeutics, a BridgeBio company 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT07608354
What this trial is testing

Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
AstraZeneca 326
Next Page